ESALY - Eisai Co. Ltd. (ESALF) Management on Q2 2021 Results - Earnings Call Transcript
Eisai Co., Ltd. (ESALF) Q2 2021 Earnings Conference Call November 5, 2020 02:00 AM ET Company Participants Ryohei Yanagi - Chief Financial Officer Ivan Cheung - Senior VP & President of Neurology Business Group Terushige Iike - Senior VP & President of Oncology Business Group Takashi Owa - VP and Chief Medicine Creation Yasushi Okada - Representative Corporate Officer and COO Teiji Kimura - Chief Discovery Officer Haruo Naito - CEO Representative Corporate Officer and Director Conference Call Participants Hidemaru Yamaguchi - Citigroup Securities Motoya Kohtani - Nomura Securities Co. Kazuaki Hashiguchi - Daiwa Securities Co. Shinichiro Muraoka - Morgan Stanley Presentation Unidentified Company Representative It is now time. We would like to begin financial results presentation for the Second Quarter of Fiscal 2020 by Eisai Company Limited. The presentation will be live streamed, or it can be heard on telephone lines. Those who are participating on the telephone lines,
For further details see:
Eisai Co., Ltd. (ESALF) Management on Q2 2021 Results - Earnings Call Transcript